STAT Plus: Pharmalittle: Glaxo is set to hire a new chairman; Gilead tries to bulk up with new deal
Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and relaxing, because that oh-so-familiar routine of meetings, deadlines, presentations, and the like has, of course, returned. What can you do? The world keeps spinning, even during the tranquil summertime. So time to get cracking as we brew another cup of stimulation — chocolate cherry decadence is our choice today — and forage for interesting items. On that note, here are some tidbits. Have a wonderful day and do keep in touch. …
GlaxoSmithKline (GSK) is set to hire Jonathan Symonds, a former finance director at AstraZeneca (AZN) and Novartis (NVS), as its new chairman to oversee a breakup of the company, The Financial Times reports. The appointment will end a six-month search for a replacement for Philip Hampton, who is currently deputy group chairman of HSBC and has been non-executive chairman at Glaxo since 2015. The move comes as Glaxo and Pfizer (PFE) plan to form a consumer health joint venture.
Continue to STAT Plus to read the full story…
